Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)'s Quarterly Revenue
TheFly reported on February 6 that Canaccord reduced its price target on PBH to $86 from $88 and maintained a Buy rating on the shares. The change came after the company reported fiscal third-quarter...




